Injectable Hydrogels Based on Cyclodextrin/Cholesterol Inclusion Complexation and Loaded with 5-Fluorouracil/Methotrexate for Breast Cancer Treatment

Breast cancer is the second most common cancer in women worldwide. Long-term treatment with conventional chemotherapy may result in severe systemic side effects. Therefore, the localized delivery of chemotherapy helps to overcome such a problem. In this article, self-assembling hydrogels were constructed via inclusion complexation between host β-cyclodextrin polymers (8armPEG20k-CD and pβ-CD) and the guest polymers 8-armed poly(ethylene glycol) capped either with cholesterol (8armPEG20k-chol) or adamantane (8armPEG20k-Ad) and were loaded with 5-fluorouracil (5-FU) and methotrexate (MTX). The prepared hydrogels were characterized by SEM and rheological behaviors. The in vitro release of 5-FU and MTX was studied. The cytotoxicity of our modified systems was investigated against breast tumor cells (MCF-7) using an MTT assay. Additionally, the histopathological changes in breast tissues were monitored before and after their intratumor injection. The results of rheological characterization indicated the viscoelastic behavior in all cases except for 8armPEG-Ad. In vitro release results showed a variable range of release profiles from 6 to 21 days, depending on the hydrogel composition. MTT findings indicated the inhibition ability of our systems against the viability of cancer cells depending on the kind and concentration of the hydrogel and the incubation period. Moreover, the results of histopathology showed the improvement of cancer manifestation (swelling and inflammation) after intratumor injection of loaded hydrogel systems. In conclusion, the obtained results indicated the applicability of the modified hydrogels as injectable vehicles for both loading and controlled release of anticancer therapies.

[1]  Tz-Feng Lin,et al.  Preparation, Structural Characterization of Anti-Cancer Drugs-Mediated Self-Assembly from the Pluronic Copolymers through Synchrotron SAXS Investigation , 2022, Materials.

[2]  Saud Almawash,et al.  Polymerized β-Cyclodextrin-Based Injectable Hydrogel for Sustained Release of 5-Fluorouracil/Methotrexate Mixture in Breast Cancer Management: In Vitro and In Vivo Analytical Validations , 2022, Pharmaceutics.

[3]  I. Saleem,et al.  Smart Injectable Chitosan Hydrogels Loaded with 5-Fluorouracil for the Treatment of Breast Cancer , 2022, Pharmaceutics.

[4]  Tz-Feng Lin,et al.  Thermosensitive Interfacial Migration of 5-FU in the Microenvironment of Pluronic Block Copolymers , 2021, Polymers.

[5]  A. Jemal,et al.  Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.

[6]  G. Nałęcz-Jawecki,et al.  Hydrogels Based on Poly(Ether-Ester)s as Highly Controlled 5-Fluorouracil Delivery Systems—Synthesis and Characterization , 2020, Materials.

[7]  Anam Ahsan,et al.  Thermosensitive Chitosan-Based Injectable Hydrogel as an Efficient Anticancer Drug Carrier , 2020, ACS omega.

[8]  M. Brzeziński,et al.  Biocompatible Polymers Combined with Cyclodextrins: Fascinating Materials for Drug Delivery Applications , 2020, Molecules.

[9]  A. Samy,et al.  In Vitro Release of 5-Fluorouracil and Methotrexate from Different Thermosensitive Chitosan Hydrogel Systems , 2020, AAPS PharmSciTech.

[10]  L. Lazzarato,et al.  Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors. , 2020, Drug resistance updates : reviews and commentaries in antimicrobial and anticancer chemotherapy.

[11]  Z. Qian,et al.  Sustained co-delivery of gemcitabine and cis-platinum via biodegradable thermo-sensitive hydrogel for synergistic combination therapy of pancreatic cancer , 2019, Nano Research.

[12]  J. Lyskawa,et al.  Smart polymeric hydrogels , 2019 .

[13]  H. S. Adhikari,et al.  Anticancer Activity of Chitosan, Chitosan Derivatives, and Their Mechanism of Action , 2018, International journal of biomaterials.

[14]  Z. Abbas,et al.  An Overview of Cancer Treatment Modalities , 2018, Neoplasm.

[15]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[16]  G. Betageri,et al.  Daptomycin Proliposomes for Oral Delivery: Formulation, Characterization, and In Vivo Pharmacokinetics , 2018, AAPS PharmSciTech.

[17]  G. Patel,et al.  Thermosensitive nanohydrogel of 5-fluorouracil for head and neck cancer: preparation, characterization and cytotoxicity assay , 2018, International journal of nanomedicine.

[18]  Z. Capáková,et al.  Chitosan-based nanocomplexes for simultaneous loading, burst reduction and controlled release of doxorubicin and 5-fluorouracil. , 2017, International journal of biological macromolecules.

[19]  C. Dwivedi,et al.  Chemoprevention of Breast Cancer by Transdermal Delivery of α-Santalol through Breast Skin and Mammary Papilla (Nipple) , 2017, Pharmaceutical Research.

[20]  A. Samy,et al.  Influence of Hydroalcoholic Vehicle on In Vitro Transport of 4-Hydroxy Tamoxifen Through the Mammary Papilla (Nipple) , 2016, AAPS PharmSciTech.

[21]  Juan Fan,et al.  Use of 5-Fluorouracil Loaded Micelles and Cisplatin in Thermosensitive Chitosan Hydrogel as an Efficient Therapy against Colorectal Peritoneal Carcinomatosis. , 2017, Macromolecular bioscience.

[22]  Xiaoliang Qi,et al.  Salecan-Based pH-Sensitive Hydrogels for Insulin Delivery. , 2017, Molecular pharmaceutics.

[23]  L. Jia,et al.  Chitosan-based nanoparticles for improved anticancer efficacy and bioavailability of mifepristone , 2016, Beilstein journal of nanotechnology.

[24]  N. Eslahi,et al.  Smart Polymeric Hydrogels for Cartilage Tissue Engineering: A Review on the Chemistry and Biological Functions. , 2016, Biomacromolecules.

[25]  Donald W. Miller,et al.  Injectable hydrogel-based drug delivery systems for local cancer therapy. , 2016, Drug discovery today.

[26]  M. Abba,et al.  DMBA induced mouse mammary tumors display high incidence of activating Pik3caH1047 and loss of function Pten mutations , 2016, Oncotarget.

[27]  Xiaoliang Qi,et al.  Smart Macroporous Salecan/Poly(N,N-diethylacrylamide) Semi-IPN Hydrogel for Anti-Inflammatory Drug Delivery. , 2016, ACS biomaterials science & engineering.

[28]  Xiaoliang Qi,et al.  Synthesis and characterization of a novel pH-thermo dual responsive hydrogel based on salecan and poly(N,N-diethylacrylamide-co-methacrylic acid). , 2015, Colloids and surfaces. B, Biointerfaces.

[29]  Xiaodong Li,et al.  An injectable drug-loaded hydrogel based on a supramolecular polymeric prodrug. , 2015, Chemical communications.

[30]  G. M. Soliman,et al.  Physically cross-linked hydrogels of β -cyclodextrin polymer and poly(ethylene glycol)-cholesterol as delivery systems for macromolecules and small drug molecules. , 2015, Current drug delivery.

[31]  M. Ahmed,et al.  In-vitro release and in-vivo performance of tolmetin from different topical gel formulations , 2015, Journal of Pharmaceutical Investigation.

[32]  Minglu Yuan,et al.  Development of a 5-fluorouracil-loaded PLGA microsphere delivery system by a solid-in-oil-in-hydrophilic oil (S/O/hO) novel method for the treatment of tumors. , 2014, Oncology reports.

[33]  I. Banerjee,et al.  Preparation and characterization of novel carbopol based bigels for topical delivery of metronidazole for the treatment of bacterial vaginosis. , 2014, Materials science & engineering. C, Materials for biological applications.

[34]  Jeong-Sook Park,et al.  Thermosensitive and Mucoadhesive Sol-Gel Composites of Paclitaxel/Dimethyl-β-Cyclodextrin for Buccal Delivery , 2014, PloS one.

[35]  Ran Tian,et al.  The development of low-molecular weight hydrogels for applications in cancer therapy. , 2014, Nanoscale.

[36]  A. Minerick,et al.  Frequency sweep rate dependence on the dielectrophoretic response of polystyrene beads and red blood cells. , 2013, Biomicrofluidics.

[37]  M. Saraswathy,et al.  Different strategies to overcome multidrug resistance in cancer. , 2013, Biotechnology advances.

[38]  M. Akashi,et al.  Tunable drug-loading capability of chitosan hydrogels with varied network architectures. , 2013, Acta biomaterialia.

[39]  Jinying Yuan,et al.  Stimuli‐Responsive Polymer Networks with β‐Cyclodextrin and Ferrocene Reversible Linkage Based on Linker Chemistry , 2013 .

[40]  Ja Gilbertson,et al.  Bancroft's Theory and Practice of Histological Techniques , 2012 .

[41]  E. Khodaverdi,et al.  In Vitro Insulin Release from Thermosensitive Chitosan Hydrogel , 2012, AAPS PharmSciTech.

[42]  Waham Ashaier Laftah,et al.  Polymer Hydrogels: A Review , 2011 .

[43]  Jörg Teßmar,et al.  Cyclodextrin based hydrogels: Inclusion complex formation and micellization of adamantane and cholesterol grafted polymers , 2011 .

[44]  P. Minghetti,et al.  Injectability Evaluation: An Open Issue , 2011, AAPS PharmSciTech.

[45]  Prasanta Chowdhury,et al.  Kinetic modeling on drug release from controlled drug delivery systems. , 2010, Acta poloniae pharmaceutica.

[46]  Jinming Gao,et al.  Multifunctional Micellar Nanomedicine for Cancer Therapy , 2009, Experimental biology and medicine.

[47]  Carsten Koopmans,et al.  Formation of Physical Hydrogels via Host−Guest Interactions of β-Cyclodextrin Polymers and Copolymers Bearing Adamantyl Groups , 2008 .

[48]  Mark E. Davis,et al.  Nanoparticle therapeutics: an emerging treatment modality for cancer , 2008, Nature Reviews Drug Discovery.

[49]  J. Varshosaz,et al.  Designing of a Thermosensitive Chitosan/Poloxamer In Situ Gel for OcularDelivery of Ciprofloxacin , 2008 .

[50]  G. Anderluh,et al.  Potentiation of anticancer-drug cytotoxicity by sea anemone pore-forming proteins in human glioblastoma cells , 2008, Anti-cancer drugs.

[51]  C. Dass,et al.  Injectable chitosan hydrogels for localised cancer therapy. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[52]  Reynaldo Villalonga,et al.  Supramolecular chemistry of cyclodextrins in enzyme technology. , 2007, Chemical reviews.

[53]  In-bog Lee,et al.  Rheological properties of resin composites according to variations in monomer and filler composition. , 2006, Dental materials : official publication of the Academy of Dental Materials.

[54]  Ruxandra Gref,et al.  New self-assembled nanogels based on host-guest interactions: characterization and drug loading. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[55]  B. Eisenberg,et al.  Surgery and Imatinib in the Management of GIST: Emerging Approaches to Adjuvant and Neoadjuvant Therapy , 2004, Annals of Surgical Oncology.

[56]  P. Mongondry,et al.  Mild Synthesis of Amino-Poly(ethylene glycol)s. Application to Steric Stabilization of Clays , 2003 .

[57]  David R. Anderson,et al.  Model selection and multimodel inference : a practical information-theoretic approach , 2003 .

[58]  F. Dosio,et al.  From Conventional to Stealth Liposomes a new Frontier in Cancer Chemotherapy , 2003, Tumori.

[59]  David R. Anderson,et al.  Model Selection and Multimodel Inference , 2003 .

[60]  S. Park,et al.  Rheological properties and microstructures of Carbopol gel network system , 2003 .

[61]  P. Gupta,et al.  Hydrogels: from controlled release to pH-responsive drug delivery. , 2002, Drug discovery today.

[62]  R. Anderson,et al.  Physicians' Cancer Chemotherapy Drug Manual 2001 , 2002, Annals of Internal Medicine.

[63]  I. Tucker,et al.  Mechanisms by which cyclodextrins modify drug release from polymeric drug delivery systems. , 2000, International journal of pharmaceutics.

[64]  P. Boccato,et al.  Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil , 2000, The British journal of ophthalmology.

[65]  C. Amiel,et al.  Interaction between an Adamantane End-Capped Poly(ethylene oxide) and a β-Cyclodextrin Polymer , 2000 .

[66]  Teruo Okano,et al.  Hydrogels: Swelling, Drug Loading, and Release , 1992, Pharmaceutical Research.

[67]  R Langer,et al.  New methods of drug delivery. , 1990, Science.

[68]  Robert B. Diasio,et al.  Clinical Pharmacology of 5-Fluorouracil , 1989, Clinical pharmacokinetics.

[69]  H. Pinedo,et al.  Fluorouracil: biochemistry and pharmacology. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[70]  R. Heimer,et al.  Enhanced 5-fluorouracil nucleotide formation after methotrexate administration: explanation for drug synergism. , 1979, Science.

[71]  W. Higuchi.  Diffusional Models Useful in Biopharmaceutics: Drug Release Rate Processes , 1967 .

[72]  C. Juan,et al.  3D-printed surgical wound dressing for prolonged 5-fluorouracil delivery from pluronic blending composites , 2022, Materials Today Communications.

[73]  M. Adeniyi,et al.  Allium Cepa Juice Prevented Oxidative Stress-Mediated Metabolic Disorder Following Chronic Lead Acetate Exposure in Male Rats , 2019 .

[74]  J. Vogel,et al.  Model Selection And Multimodel Inference , 2016 .

[75]  Jacqueline Cloos,et al.  Cell sensitivity assays: the MTT assay. , 2011, Methods in molecular biology.

[76]  D. Koch,et al.  Scanning electron microscopic analysis of foldable acrylic and hydrogel intraocular lenses , 1996, Journal of cataract and refractive surgery.

[77]  G. Tibbetts.  Growing carbon fibers with a linearly increasing temperature sweep: Experiments and modeling , 1992 .